Last reviewed · How we verify

NCT03302533

Can Secondary Total Elbow Arthroplasty After Failed Internal Fixation or Non-operative Treatment of Distal Humeral Fractures Achieve Equal Results as Primary Arthroplasty?

Completed Last updated 5 October 2017
What this trial tests

trial testing Total elbow arthroplasty in Elbow Fracture in 23 participants. Completed in 31 March 2017.

Timeline
21 January 2013
Primary endpoint
31 March 2016
31 March 2017

Quick facts

Lead sponsorDiakoniekrankenhaus Friederikenstift
StatusCompleted
Study typeOBSERVATIONAL
Enrollment23
Start date21 January 2013
Primary completion31 March 2016
Estimated completion31 March 2017

Drugs / interventions tested

Conditions studied

Sponsor

Diakoniekrankenhaus Friederikenstift

Who can join

18 and older, any sex, with Elbow Fracture or Elbow Arthropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Total elbow arthroplasty (TEA) results in immediate pain release with good functional results after distal humerus fractures. But still open reduction and internal fixation is recommended as treatment of choise due to a lifelong loading limitiation, unknown implant survival and problematic revision surgery after TEA. The purpose of this study was to compare functional results and complication rates after primary total elbow arthroplasty (TEA) and TEA after failed reconstruction or non-operative treatment (secondary TEA) in the treatment of distal humerus fractures. We hypothesised that clinical and functional results are better for primary TEA with less complications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Total elbow arthroplasty

Trials testing the same drug.

Other Diakoniekrankenhaus Friederikenstift trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03302533.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing